Cibc World Market Inc. cut its position in CVS Health Corporation (NYSE:CVS – Free Report) by 9.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 470,916 shares of the pharmacy operator’s stock after selling 51,127 shares during the quarter. Cibc World Market Inc.’s holdings in CVS Health were worth $40,353,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of CVS. Vawter Financial Ltd. acquired a new stake in shares of CVS Health in the third quarter valued at approximately $257,000. Edgestream Partners L.P. acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $4,610,000. Banco Santander S.A. increased its holdings in shares of CVS Health by 156.1% during the 3rd quarter. Banco Santander S.A. now owns 8,036 shares of the pharmacy operator’s stock worth $689,000 after acquiring an additional 4,898 shares during the last quarter. Western Wealth Management LLC increased its holdings in shares of CVS Health by 10.8% during the 3rd quarter. Western Wealth Management LLC now owns 3,889 shares of the pharmacy operator’s stock worth $333,000 after acquiring an additional 380 shares during the last quarter. Finally, Intech Investment Management LLC raised its stake in CVS Health by 184.1% in the 3rd quarter. Intech Investment Management LLC now owns 151,876 shares of the pharmacy operator’s stock valued at $13,014,000 after acquiring an additional 98,422 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.
CVS Health Stock Down 5.2%
CVS opened at $81.33 on Thursday. The stock has a fifty day moving average of $89.00 and a 200-day moving average of $89.25. The company has a market capitalization of $104.05 billion, a P/E ratio of 9.47, a P/E/G ratio of 0.75 and a beta of 0.58. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85.
CVS Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s payout ratio is currently 30.97%.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on CVS. BMO Capital Markets set a $112.00 price target on CVS Health in a report on Wednesday, September 9th. Wells Fargo & Company decreased their price objective on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday, November 12th. Wall Street Zen lowered shares of CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Leerink Partners cut their target price on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a research note on Thursday, November 5th. Finally, Barclays cut their target price on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research note on Thursday, November 5th. Twenty-three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $107.33.
View Our Latest Research Report on CVS
Latest CVS Health News
These are some of the CVS news items that stood out recently:
- Positive Sentiment: A CVS study suggests GLP-1 medications could reduce overall healthcare spending if their net price is $350 or less. That could support wider use of the drugs, though the savings depend on affordability and access. CVS Health Study Says GLP-1s Save Money If Net Price Is $350 Or Lower
- Negative Sentiment: Proposed CMS Medicare Advantage audit rules could expand the financial consequences of audit findings and require reporting suspected fraud, raising regulatory and reimbursement risks for Aetna. CVS Health Stocks Fall as Aetna Faces Tougher Medicare Advantage Audit Rules
- Negative Sentiment: Coverage also flagged the risk that higher medical costs could pressure CVS’s earnings, while RBC issued a pessimistic stock-price forecast. The lack of a dividend increase may further disappoint income-focused investors. How Bad Would Higher Medical Costs Be For CVS Health Stock? Royal Bank of Canada Issues Pessimistic Forecast for CVS Health Stock Price
Insider Activity
In other CVS Health news, EVP Prem Shah bought 23,855 shares of the firm’s stock in a transaction on Friday, November 6th. The shares were purchased at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the transaction, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.85% of the stock is currently owned by insiders.
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
See Also
- Five stocks we like better than CVS Health
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
